Arcoscreen
Geneva, Switzerland· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Arcoscreen is a Swiss biotechnology company founded in 2020, based in Geneva. It has developed a proprietary platform, Arcoflow, for screening G protein-coupled receptor (GPCR) drugs directly in primary patient cells. The company's mission is to help pharmaceutical companies identify promising GPCR drug candidates more efficiently, aiming to accelerate the transition from research to clinical trials.
DiagnosticsInfectious Disease